Advocacy at a Glance STEVEN GROSSMAN 5/8/20 Advocacy at a Glance STEVEN GROSSMAN 5/8/20 House and Senate Appropriations Committees Still Committed, Off to a Slow Start Read More Advocacy at a Glance STEVEN GROSSMAN 8/24/18 Advocacy at a Glance STEVEN GROSSMAN 8/24/18 Senate Finishes Consideration of DoD/Labor-HHS Mini-bus Funding Bill and more Read More Advocacy at a Glance STEVEN GROSSMAN 8/17/18 Advocacy at a Glance STEVEN GROSSMAN 8/17/18 Sometimes There Really Is a Win-Win Read More Advocacy at a Glance STEVEN GROSSMAN 8/17/18 Advocacy at a Glance STEVEN GROSSMAN 8/17/18 Ag/FDA Moves in the Senate Read More Advocacy at a Glance STEVEN GROSSMAN 6/29/18 Advocacy at a Glance STEVEN GROSSMAN 6/29/18 Last Chance to Join Alliance Sign-On Letter to Appropriators and more Read More Advocacy at a Glance STEVEN GROSSMAN 6/1/18 Advocacy at a Glance STEVEN GROSSMAN 6/1/18 FDA Appropriations Likely to Move Early Read More Advocacy at a Glance STEVEN GROSSMAN 12/1/17 Advocacy at a Glance STEVEN GROSSMAN 12/1/17 CR Runs Out on December 8: Will There Be a Budget Deal or a Shutdown and more Read More Advocacy at a Glance STEVEN GROSSMAN 7/14/17 Advocacy at a Glance STEVEN GROSSMAN 7/14/17 FDA Starts FY 19 Budget Planning Long Before FY 18 Process is Completed and more Read More Advocacy at a Glance STEVEN GROSSMAN 6/30/17 Advocacy at a Glance STEVEN GROSSMAN 6/30/17 User fees in House Appropriations Bill Consistent With FDARA Numbers and more Read More Advocacy at a Glance STEVEN GROSSMAN 3/24/17 Advocacy at a Glance STEVEN GROSSMAN 3/24/17 President’s Budget Blueprint Puts FDA at Risk and more Read More Advocacy at a Glance STEVEN GROSSMAN 12/16/16 Advocacy at a Glance STEVEN GROSSMAN 12/16/16 FY 17 Continuing Resolution to Run Through April 28, 2017 Read More Analysis and Commentary STEVEN GROSSMAN 12/9/16 Analysis and Commentary STEVEN GROSSMAN 12/9/16 Setting the Advocacy Stage for FY 18 and After Read More Advocacy at a Glance STEVEN GROSSMAN 12/9/16 Advocacy at a Glance STEVEN GROSSMAN 12/9/16 Continuing Resolution Close, But May Not Make Friday Night Deadline Read More Analysis and Commentary STEVEN GROSSMAN 12/5/16 Analysis and Commentary STEVEN GROSSMAN 12/5/16 21st Century Cures Passes House -- with Pros and Cons Read More Advocacy at a Glance STEVEN GROSSMAN 12/5/16 Advocacy at a Glance STEVEN GROSSMAN 12/5/16 21st Century Cures Passes House; Set for Senate Vote Next Week Read More Advocacy at a Glance STEVEN GROSSMAN 10/1/16 Advocacy at a Glance STEVEN GROSSMAN 10/1/16 CR through December 9 Passes; Congress in Recess Read More Advocacy at a Glance STEVEN GROSSMAN 6/10/16 Advocacy at a Glance STEVEN GROSSMAN 6/10/16 Speaker Ryan Changes Floor Rules to Expedite Appropriations Bills Read More Advocacy at a Glance STEVEN GROSSMAN 4/22/16 Advocacy at a Glance STEVEN GROSSMAN 4/22/16 Califf Speech to Alliance a Huge Success Read More Analysis and Commentary STEVEN GROSSMAN 4/15/16 Analysis and Commentary STEVEN GROSSMAN 4/15/16 Give Us Something We Can Support! Read More Analysis and Commentary STEVEN GROSSMAN 1/23/16 Analysis and Commentary STEVEN GROSSMAN 1/23/16 Why Have We Watched "Cures" So Closely? Read More Older Posts
Advocacy at a Glance STEVEN GROSSMAN 5/8/20 Advocacy at a Glance STEVEN GROSSMAN 5/8/20 House and Senate Appropriations Committees Still Committed, Off to a Slow Start Read More
Advocacy at a Glance STEVEN GROSSMAN 8/24/18 Advocacy at a Glance STEVEN GROSSMAN 8/24/18 Senate Finishes Consideration of DoD/Labor-HHS Mini-bus Funding Bill and more Read More
Advocacy at a Glance STEVEN GROSSMAN 8/17/18 Advocacy at a Glance STEVEN GROSSMAN 8/17/18 Sometimes There Really Is a Win-Win Read More
Advocacy at a Glance STEVEN GROSSMAN 8/17/18 Advocacy at a Glance STEVEN GROSSMAN 8/17/18 Ag/FDA Moves in the Senate Read More
Advocacy at a Glance STEVEN GROSSMAN 6/29/18 Advocacy at a Glance STEVEN GROSSMAN 6/29/18 Last Chance to Join Alliance Sign-On Letter to Appropriators and more Read More
Advocacy at a Glance STEVEN GROSSMAN 6/1/18 Advocacy at a Glance STEVEN GROSSMAN 6/1/18 FDA Appropriations Likely to Move Early Read More
Advocacy at a Glance STEVEN GROSSMAN 12/1/17 Advocacy at a Glance STEVEN GROSSMAN 12/1/17 CR Runs Out on December 8: Will There Be a Budget Deal or a Shutdown and more Read More
Advocacy at a Glance STEVEN GROSSMAN 7/14/17 Advocacy at a Glance STEVEN GROSSMAN 7/14/17 FDA Starts FY 19 Budget Planning Long Before FY 18 Process is Completed and more Read More
Advocacy at a Glance STEVEN GROSSMAN 6/30/17 Advocacy at a Glance STEVEN GROSSMAN 6/30/17 User fees in House Appropriations Bill Consistent With FDARA Numbers and more Read More
Advocacy at a Glance STEVEN GROSSMAN 3/24/17 Advocacy at a Glance STEVEN GROSSMAN 3/24/17 President’s Budget Blueprint Puts FDA at Risk and more Read More
Advocacy at a Glance STEVEN GROSSMAN 12/16/16 Advocacy at a Glance STEVEN GROSSMAN 12/16/16 FY 17 Continuing Resolution to Run Through April 28, 2017 Read More
Analysis and Commentary STEVEN GROSSMAN 12/9/16 Analysis and Commentary STEVEN GROSSMAN 12/9/16 Setting the Advocacy Stage for FY 18 and After Read More
Advocacy at a Glance STEVEN GROSSMAN 12/9/16 Advocacy at a Glance STEVEN GROSSMAN 12/9/16 Continuing Resolution Close, But May Not Make Friday Night Deadline Read More
Analysis and Commentary STEVEN GROSSMAN 12/5/16 Analysis and Commentary STEVEN GROSSMAN 12/5/16 21st Century Cures Passes House -- with Pros and Cons Read More
Advocacy at a Glance STEVEN GROSSMAN 12/5/16 Advocacy at a Glance STEVEN GROSSMAN 12/5/16 21st Century Cures Passes House; Set for Senate Vote Next Week Read More
Advocacy at a Glance STEVEN GROSSMAN 10/1/16 Advocacy at a Glance STEVEN GROSSMAN 10/1/16 CR through December 9 Passes; Congress in Recess Read More
Advocacy at a Glance STEVEN GROSSMAN 6/10/16 Advocacy at a Glance STEVEN GROSSMAN 6/10/16 Speaker Ryan Changes Floor Rules to Expedite Appropriations Bills Read More
Advocacy at a Glance STEVEN GROSSMAN 4/22/16 Advocacy at a Glance STEVEN GROSSMAN 4/22/16 Califf Speech to Alliance a Huge Success Read More
Analysis and Commentary STEVEN GROSSMAN 4/15/16 Analysis and Commentary STEVEN GROSSMAN 4/15/16 Give Us Something We Can Support! Read More
Analysis and Commentary STEVEN GROSSMAN 1/23/16 Analysis and Commentary STEVEN GROSSMAN 1/23/16 Why Have We Watched "Cures" So Closely? Read More
